143 related articles for article (PubMed ID: 11483401)
61. Association between Campylobacter infection and Guillain-Barré syndrome.
Allos BM
J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
[TBL] [Abstract][Full Text] [Related]
62. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
[TBL] [Abstract][Full Text] [Related]
63. Guillain-Barré syndrome subtypes related to Campylobacter infection.
Drenthen J; Yuki N; Meulstee J; Maathuis EM; van Doorn PA; Visser GH; Blok JH; Jacobs BC
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):300-5. PubMed ID: 21270063
[TBL] [Abstract][Full Text] [Related]
64. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
65. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome?
Berciano J; Illa I
Neurology; 2005 Feb; 64(4):766-7; author reply 766-7. PubMed ID: 15728323
[No Abstract] [Full Text] [Related]
66. [Campylobacter jejuni and autoimmune-mediated neurologic diseases: pathogenesis of Guillain-Barré syndrome and Fisher's syndrome].
Yuki N
Nihon Saikingaku Zasshi; 1995 Oct; 50(4):991-1003. PubMed ID: 8544349
[No Abstract] [Full Text] [Related]
67. Fulminant Guillain-Barré syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody.
Okuda B; Koga M; Katsuta T; Okamoto K; Yuki N
Intern Med; 2002 Oct; 41(10):889-91. PubMed ID: 12413017
[TBL] [Abstract][Full Text] [Related]
68. Serum antibody level against GroEL type heat-shock protein of Campylobacter jejuni in patients with Guillain-Barré syndrome.
Fujimoto S; Fujita M
Microbiol Immunol; 1999; 43(3):241-4. PubMed ID: 10338193
[TBL] [Abstract][Full Text] [Related]
69. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.
Chiba A; Kusunoki S; Obata H; Machinami R; Kanazawa I
Neurology; 1993 Oct; 43(10):1911-7. PubMed ID: 8413947
[TBL] [Abstract][Full Text] [Related]
70. Campylobacter 0:41 isolation in Guillain-Barré syndrome.
Goddard EA; Lastovica AJ; Argent AC
Arch Dis Child; 1997 Jun; 76(6):526-8. PubMed ID: 9245852
[TBL] [Abstract][Full Text] [Related]
71. Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups.
van der Meché FG; Visser LH; Jacobs BC; Endtz HP; Meulstee J; van Doorn PA
J Infect Dis; 1997 Dec; 176 Suppl 2():S99-102. PubMed ID: 9396690
[TBL] [Abstract][Full Text] [Related]
72. [Guillain-Barré syndrome preceded by diarrhea with the infection of Campylobacter jejuni].
Yamada S; Bandoh M; Nagura H; Yamanouchi H; Inamatsu T
Rinsho Shinkeigaku; 1991 Aug; 31(8):882-4. PubMed ID: 1764866
[TBL] [Abstract][Full Text] [Related]
73. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
74. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
[TBL] [Abstract][Full Text] [Related]
75. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study.
Kalra V; Chaudhry R; Dua T; Dhawan B; Sahu JK; Mridula B
J Child Neurol; 2009 Jun; 24(6):664-8. PubMed ID: 19491112
[TBL] [Abstract][Full Text] [Related]
76. Fisher syndrome after Campylobacter jejuni enteritis: human leukocyte antigen and the bacterial serotype.
Yuki N; Ichikawa H; Doi A
J Pediatr; 1995 Jan; 126(1):55-7. PubMed ID: 7815224
[TBL] [Abstract][Full Text] [Related]
77. Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease.
Taylor BV; Williamson J; Jones D; Coleman D; Luck J; McGregor A
J Clin Neurosci; 2007 Feb; 14(2):116-21. PubMed ID: 17107803
[TBL] [Abstract][Full Text] [Related]
78. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
[TBL] [Abstract][Full Text] [Related]
79. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
80. [Anti-GQ1b antibodies: usefulness of its detection for the diagnosis of Miller-Fisher syndrome].
Rojas-García R; Gallardo E; Serrano-Munuera C; de Luna N; Ortiz E; Roig C; Grau-Veciana JM; Illa I
Med Clin (Barc); 2001 Jun; 116(20):761-4. PubMed ID: 11440679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
